| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.847 | 0.002 | 0.847 | Nav1.1 sodium channel blocker | 0.452 0.004 CID_154700008 | ||
| 0.655 | 0.005 | 0.655 | Anticonvulsant | 0.342 0.031 CID_154700008 | ||
| 0.649 | 0.013 | 0.649 | Aldehyde oxidase inhibitor | |||
| 0.618 | 0.006 | 0.618 | Superoxide dismutase inhibitor | |||
| 0.571 | 0.004 | 0.571 | Tumour necrosis factor antagonist | |||
| 0.54 | 0.003 | 0.54 | Alcohol dehydrogenase inhibitor | 0.294 0.005 CID_154700008 | ||
| 0.388 | 0.008 | 0.388 | Interleukin 6 antagonist | 0.306 0.014 CID_154700008 | ||
| 0.404 | 0.06 | 0.404 | GABA C receptor rho-3 antagonist | |||
| 0.353 | 0.024 | 0.425 | RNA-directed DNA polymerase inhibitor | 0.425 0.016 CID_154700008 | CID_154700008 | |
| 0.333 | 0.02 | 0.333 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.369 | 0.069 | 0.369 | Thioredoxin glutathione reductase inhibitor | |||
| 0.309 | 0.014 | 0.309 | Nav1.2 sodium channel blocker | |||
| 0.288 | 0.004 | 0.288 | Liver X receptor agonist | 0.083 0.01 CID_154700008 | ||
| 0.313 | 0.03 | 0.313 | Anesthetic general | |||
| 0.378 | 0.097 | 0.378 | Calcium channel L-type activator | |||
| 0.306 | 0.036 | 0.306 | Peroxidase inhibitor | |||
| 0.263 | 0.008 | 0.263 | Nav1.6 sodium channel blocker | |||
| 0.28 | 0.033 | 0.379 | Peptidyltransferase inhibitor | 0.379 0.009 CID_154700008 | CID_154700008 | |
| 0.244 | 0.003 | 0.244 | Aggrecanase 1 inhibitor | |||
| 0.287 | 0.059 | 0.287 | Tumour necrosis factor alpha release inhibitor | |||
| 0.262 | 0.04 | 0.262 | Growth hormone agonist | |||
| 0.269 | 0.056 | 0.513 | DNA synthesis inhibitor | 0.513 0.012 CID_154700008 | CID_154700008 | |
| 0.355 | 0.142 | 0.423 | Caspase 9 stimulant | 0.423 0.098 CID_154700008 | CID_154700008 | |
| 0.259 | 0.048 | 0.259 | Neuropeptide Y2 antagonist | |||
| 0.218 | 0.019 | 0.218 | Nav1.3 sodium channel blocker | |||
| 0.285 | 0.091 | 0.53 | Immunomodulator | 0.53 0.019 CID_154700008 | CID_154700008 | |
| 0.207 | 0.013 | 0.207 | DNA directed RNA polymerase inhibitor | 0.167 0.019 CID_154700008 | ||
| 0.236 | 0.043 | 0.236 | Nitric-oxide synthase stimulant | |||
| 0.249 | 0.064 | 0.421 | Cyclic AMP phosphodiesterase inhibitor | 0.421 0.014 CID_154700008 | CID_154700008 | |
| 0.197 | 0.018 | 0.456 | UDP-glucose 4-epimerase inhibitor | 0.456 0.004 CID_154700008 | CID_154700008 | |
| 0.287 | 0.131 | 0.287 | Histamine release inhibitor | 0.248 0.157 CID_154700008 | ||
| 0.185 | 0.038 | 0.185 | GABA C receptor rho-2 antagonist | |||
| 0.24 | 0.094 | 0.24 | 5 Hydroxytryptamine release stimulant | |||
| 0.283 | 0.142 | 0.283 | Beta lactamase inhibitor | |||
| 0.158 | 0.021 | 0.158 | Creatine kinase inhibitor | |||
| 0.164 | 0.035 | 0.164 | Cystathionine beta-synthase inhibitor | |||
| 0.138 | 0.012 | 0.138 | Aldose reductase inhibitor | |||
| 0.248 | 0.13 | 0.248 | Sodium/bile acid cotransporter inhibitor | 0.206 0.18 CID_154700008 | ||
| 0.224 | 0.111 | 0.224 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.194 | 0.082 | 0.194 | Neurotrophic factor enhancer | |||
| 0.243 | 0.132 | 0.336 | Transcription factor NF kappa B inhibitor | 0.336 0.081 CID_154700008 | CID_154700008 | |
| 0.118 | 0.007 | 0.118 | Macrophage elastase inhibitor | |||
| 0.288 | 0.18 | 0.288 | 5 Hydroxytryptamine release inhibitor | |||
| 0.112 | 0.004 | 0.112 | Nicotinic acid receptor agonist | |||
| 0.116 | 0.01 | 0.116 | Androgen agonist | |||
| 0.168 | 0.066 | 0.168 | Neurotensin receptor agonist | |||
| 0.122 | 0.021 | 0.122 | Keratolytic | |||
| 0.134 | 0.034 | 0.134 | Estrogen antagonist | |||
| 0.132 | 0.033 | 0.132 | DOPA decarboxylase inhibitor | |||
| 0.129 | 0.031 | 0.129 | Anabolic | 0.102 0.06 CID_154700008 | ||
| 0.102 | 0.006 | 0.102 | MDM2 inhibitor | |||
| 0.13 | 0.034 | 0.303 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.303 0.006 CID_154700008 | CID_154700008 | |
| 0.12 | 0.032 | 0.12 | Estrogen receptor beta antagonist | |||
| 0.108 | 0.027 | 0.108 | HIV-1 reverse transcriptase inhibitor | 0.065 0.053 CID_154700008 | ||
| 0.148 | 0.068 | 0.208 | Cell wall synthesis inhibitor | 0.208 0.027 CID_154700008 | CID_154700008 | |
| 0.098 | 0.019 | 0.098 | Alcohol oxidase inhibitor | |||
| 0.224 | 0.145 | 0.454 | Cholesterol antagonist | 0.454 0.04 CID_154700008 | CID_154700008 | |
| 0.112 | 0.034 | 0.243 | NADH dehydrogenase inhibitor | 0.243 0.008 CID_154700008 | CID_154700008 | |
| 0.11 | 0.034 | 0.11 | Metalloproteinase-2 inhibitor | |||
| 0.082 | 0.005 | 0.082 | Pregnane X receptor antagonist | |||
| 0.114 | 0.038 | 0.114 | NMDA receptor antagonist | |||
| 0.084 | 0.009 | 0.084 | Dihydroorotate oxidase inhibitor | |||
| 0.117 | 0.042 | 0.117 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.134 | 0.061 | 0.134 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.173 | 0.101 | 0.173 | Interleukin antagonist | |||
| 0.135 | 0.064 | 0.135 | Alpha-N-acetylglucosaminidase inhibitor | 0.109 0.09 CID_154700008 | ||
| 0.161 | 0.091 | 0.161 | Lipocortins synthesis antagonist | 0.155 0.098 CID_154700008 | ||
| 0.073 | 0.004 | 0.073 | Aggrecanase 2 inhibitor | |||
| 0.1 | 0.032 | 0.1 | Metalloproteinase-9 inhibitor | |||
| 0.143 | 0.075 | 0.146 | Adenylate cyclase stimulant | 0.146 0.069 CID_154700008 | CID_154700008 | |
| 0.148 | 0.08 | 0.148 | CF transmembrane conductance regulator agonist | |||
| 0.118 | 0.051 | 0.118 | GABA C receptor agonist | |||
| 0.094 | 0.028 | 0.094 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.076 | 0.011 | 0.076 | Kinesin-like protein 1 inhibitor | |||
| 0.076 | 0.011 | 0.076 | Kinesin antagonist | |||
| 0.22 | 0.157 | 0.291 | Interleukin 2 agonist | 0.291 0.081 CID_154700008 | CID_154700008 | |
| 0.073 | 0.012 | 0.073 | Nicotinic acid receptor 1 agonist | |||
| 0.101 | 0.04 | 0.101 | Interleukin 5 antagonist | |||
| 0.093 | 0.034 | 0.093 | Estrogen-related receptor beta agonist | |||
| 0.068 | 0.009 | 0.068 | Liver X receptor alpha agonist | |||
| 0.109 | 0.051 | 0.109 | GABA C receptor rho-1 antagonist | |||
| 0.113 | 0.06 | 0.113 | GABA C receptor antagonist | |||
| 0.113 | 0.059 | 0.113 | Ferrochelatase inhibitor | |||
| 0.156 | 0.102 | 0.156 | Succinate dehydrogenase inhibitor | |||
| 0.059 | 0.006 | 0.07 | Uridine phosphorylase inhibitor | 0.07 0.004 CID_154700008 | CID_154700008 | |
| 0.204 | 0.151 | 0.204 | Insulysin inhibitor | |||
| 0.09 | 0.037 | 0.09 | Histidine decarboxylase inhibitor | |||
| 0.088 | 0.037 | 0.239 | Phosphofructokinase-1 inhibitor | 0.239 0.008 CID_154700008 | CID_154700008 | |
| 0.213 | 0.162 | 0.448 | Antithrombotic | 0.448 0.038 CID_154700008 | CID_154700008 | |
| 0.077 | 0.028 | 0.15 | Biliverdin reductase inhibitor | 0.15 0.009 CID_154700008 | CID_154700008 | |
| 0.082 | 0.034 | 0.082 | Secretase beta inhibitor | |||
| 0.136 | 0.089 | 0.136 | Ca2+-transporting ATPase inhibitor | |||
| 0.086 | 0.039 | 0.086 | Glutamate decarboxylase inhibitor | |||
| 0.052 | 0.01 | 0.052 | Liver X receptor beta agonist | |||
| 0.163 | 0.121 | 0.315 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.315 0.019 CID_154700008 | CID_154700008 | |
| 0.056 | 0.014 | 0.056 | Dopamine D5 agonist | |||
| 0.045 | 0.004 | 0.045 | Nicotinic acid receptor 2 antagonist | |||
| 0.097 | 0.058 | 0.097 | Prolactin inhibitor | |||
| 0.07 | 0.032 | 0.07 | Collagenase 3 inhibitor | |||
| 0.083 | 0.045 | 0.083 | Porphobilinogen synthase inhibitor | |||
| 0.05 | 0.014 | 0.05 | Nicotinic acid receptor 2 agonist | |||
| 0.075 | 0.04 | 0.075 | Matrix metalloproteinase inhibitor | |||
| 0.137 | 0.104 | 0.137 | Arachidonic acid antagonist | |||
| 0.124 | 0.09 | 0.124 | Lipid peroxidase inhibitor | 0.124 0.09 CID_154700008 | ||
| 0.048 | 0.016 | 0.048 | Kainate receptor agonist | |||
| 0.103 | 0.072 | 0.103 | 5 Hydroxytryptamine 3A agonist | |||
| 0.135 | 0.105 | 0.135 | Melanin inhibitor | |||
| 0.037 | 0.008 | 0.037 | Thyroid hormone agonist | |||
| 0.063 | 0.034 | 0.171 | Argininosuccinate synthase inhibitor | 0.171 0.009 CID_154700008 | CID_154700008 | |
| 0.117 | 0.09 | 0.117 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.047 | 0.021 | 0.053 | Thymidine kinase inhibitor | 0.053 0.017 CID_154700008 | CID_154700008 | |
| 0.092 | 0.069 | 0.092 | Xanthine oxidase inhibitor | |||
| 0.056 | 0.037 | 0.056 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.06 | 0.043 | 0.108 | Carbamoyl phosphate synthetase inhibitor | 0.108 0.018 CID_154700008 | CID_154700008 | |
| 0.03 | 0.012 | 0.03 | Thymidine phosphorylase inhibitor | 0.024 0.023 CID_154700008 | ||
| 0.056 | 0.039 | 0.095 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.095 0.015 CID_154700008 | CID_154700008 | |
| 0.022 | 0.005 | 0.022 | Thyroid hormone alpha agonist | |||
| 0.036 | 0.02 | 0.036 | ADAM10 endopeptidase inhibitor | |||
| 0.208 | 0.192 | 0.208 | Toll-Like receptor 7 agonist | |||
| 0.06 | 0.044 | 0.06 | NMDA 2C receptor antagonist | |||
| 0.041 | 0.025 | 0.041 | Membrane dipeptidase inhibitor | |||
| 0.164 | 0.149 | 0.25 | Antioxidant | 0.25 0.084 CID_154700008 | CID_154700008 | |
| 0.03 | 0.015 | 0.03 | DNA polymerase III inhibitor | |||
| 0.096 | 0.083 | 0.139 | Mucolytic | 0.139 0.04 CID_154700008 | CID_154700008 | |
| 0.151 | 0.138 | 0.151 | Histone acetyltransferase inhibitor | |||
| 0.068 | 0.057 | 0.068 | Phospholipase D inhibitor | |||
| 0.022 | 0.01 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.05 | 0.038 | 0.05 | NMDA 2A receptor antagonist | |||
| 0.027 | 0.016 | 0.032 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.032 0.009 CID_154700008 | CID_154700008 | |
| 0.075 | 0.065 | 0.075 | Glycine receptor antagonist | |||
| 0.06 | 0.05 | 0.06 | Phosphodiesterase 1C inhibitor | |||
| 0.033 | 0.023 | 0.033 | Protein kinase (CK2) beta inhibitor | |||
| 0.079 | 0.071 | 0.079 | D-Ala-D-Ala ligase inhibitor | |||
| 0.139 | 0.131 | 0.186 | Phospholipase C inhibitor | 0.186 0.055 CID_154700008 | CID_154700008 | |
| 0.059 | 0.052 | 0.059 | Beta 2 adrenoreceptor agonist | |||
| 0.011 | 0.004 | 0.011 | DNA topoisomerase III inhibitor | |||
| 0.053 | 0.046 | 0.053 | Fatty acid synthase inhibitor | |||
| 0.108 | 0.102 | 0.164 | DNA repair enzyme inhibitor | 0.164 0.021 CID_154700008 | CID_154700008 | |
| 0.059 | 0.053 | 0.059 | Phosphodiesterase III inhibitor | |||
| 0.073 | 0.068 | 0.073 | MAP kinase kinase 7 inhibitor | |||
| 0.014 | 0.009 | 0.014 | DNA polymerase III polC-type inhibitor | |||
| 0.203 | 0.198 | 0.203 | Toll-Like receptor agonist | |||
| 0.094 | 0.09 | 0.161 | Adenylate cyclase inhibitor | 0.161 0.038 CID_154700008 | CID_154700008 | |
| 0.056 | 0.053 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.067 | 0.065 | 0.067 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.008 | 0.007 | 0.008 | Thyroid hormone beta agonist | |||
| 0.055 | 0.054 | 0.055 | Ryanodine receptor antagonist | |||
| 0.028 | 0.035 | 0.051 | Purinergic P2Y2 antagonist | 0.051 0.01 CID_154700008 | CID_154700008 | |
| 0.026 | 0.036 | 0.064 | Fumarate hydratase inhibitor | 0.064 0.009 CID_154700008 | CID_154700008 | |
| 0.088 | 0.1 | 0.263 | DNA polymerase I inhibitor | 0.263 0.015 CID_154700008 | CID_154700008 | |
| 0.086 | 0.098 | 0.172 | Adenylate kinase inhibitor | 0.172 0.02 CID_154700008 | CID_154700008 | |
| 0.126 | 0.14 | 0.146 | Psychostimulant | 0.146 0.12 CID_154700008 | CID_154700008 | |
| 0.127 | 0.142 | 0.17 | Heat shock protein 70 antagonist | 0.17 0.018 CID_154700008 | CID_154700008 | |
| 0.141 | 0.157 | 0.21 | Free radical scavenger | 0.21 0.09 CID_154700008 | CID_154700008 | |
| 0.007 | 0.022 | 0.013 | Purinergic P2Y2 agonist | 0.013 0.005 CID_154700008 | CID_154700008 | |
| 0.048 | 0.068 | 0.081 | Adenine nucleotide translocase inhibitor | 0.081 0.009 CID_154700008 | CID_154700008 | |
| 0.078 | 0.1 | 0.236 | Expectorant | 0.236 0.014 CID_154700008 | CID_154700008 | |
| 0.058 | 0.081 | 0.117 | Glutamate dehydrogenase inhibitor | 0.117 0.023 CID_154700008 | CID_154700008 | |
| 0.034 | 0.061 | 0.07 | Ornithine carbamoyltransferase inhibitor | 0.07 0.026 CID_154700008 | CID_154700008 | |
| 0.005 | 0.033 | 0.022 | Purinergic P2Y agonist | 0.022 0.005 CID_154700008 | CID_154700008 | |
| 0.005 | 0.034 | 0.027 | Purinergic P2 agonist | 0.027 0.005 CID_154700008 | CID_154700008 | |
| 0.005 | 0.034 | 0.027 | Purinergic receptor agonist | 0.027 0.005 CID_154700008 | CID_154700008 | |
| 0.108 | 0.141 | 0.185 | NOS3 expression enhancer | 0.185 0.048 CID_154700008 | CID_154700008 | |
| 0.028 | 0.066 | 0.073 | Antimetabolite | 0.073 0.021 CID_154700008 | CID_154700008 | |
| 0.172 | 0.21 | 0.394 | Vasodilator, coronary | 0.394 0.037 CID_154700008 | CID_154700008 | |
| 0.017 | 0.057 | 0.032 | Sodium/glucose cotransporter inhibitor | 0.032 0.01 CID_154700008 | CID_154700008 | |
| 0.13 | 0.175 | 0.374 | Immunostimulant | 0.374 0.058 CID_154700008 | CID_154700008 | |
| 0.041 | 0.096 | 0.084 | Purinergic P2X1 antagonist | 0.084 0.023 CID_154700008 | CID_154700008 | |
| 0.074 | 0.133 | 0.108 | Amylase inhibitor | 0.108 0.09 CID_154700008 | CID_154700008 | |
| 0.123 | 0.191 | 0.257 | Interleukin agonist | 0.257 0.073 CID_154700008 | CID_154700008 | |
| 0.124 | 0.193 | 0.181 | Spasmolytic | 0.181 0.136 CID_154700008 | CID_154700008 | |
| 0.012 | 0.081 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 CID_154700008 | CID_154700008 | |
| 0.078 | 0.148 | 0.117 | Aldehyde dehydrogenase inhibitor | 0.117 0.074 CID_154700008 | CID_154700008 | |
| 0.095 | 0.167 | 0.171 | Hexokinase inhibitor | 0.171 0.057 CID_154700008 | CID_154700008 | |
| 0.026 | 0.106 | 0.052 | Acyl-CoA dehydrogenase inhibitor | 0.052 0.04 CID_154700008 | CID_154700008 | |
| 0.019 | 0.107 | 0.055 | Adenosine deaminase inhibitor | 0.055 0.026 CID_154700008 | CID_154700008 | |
| 0.107 | 0.196 | 0.17 | Hypolipemic | 0.17 0.118 CID_154700008 | CID_154700008 | |
| 0.009 | 0.109 | 0.029 | Sodium/glucose cotransporter 2 inhibitor | 0.029 0.014 CID_154700008 | CID_154700008 | |
| 0.063 | 0.163 | 0.102 | Alkylator | 0.102 0.086 CID_154700008 | CID_154700008 | |
| 0.141 | 0.256 | 0.366 | Vasodilator, peripheral | 0.366 0.067 CID_154700008 | CID_154700008 | |
| 0.015 | 0.134 | 0.054 | Phosphorylase inhibitor | 0.054 0.028 CID_154700008 | CID_154700008 | |
| 0.143 | 0.265 | 0.321 | Immunosuppressant | 0.321 0.102 CID_154700008 | CID_154700008 | |
| 0.042 | 0.165 | 0.241 | Topoisomerase I inhibitor | 0.241 0.018 CID_154700008 | CID_154700008 | |
| 0.041 | 0.167 | 0.081 | Adenosine A3 receptor antagonist | 0.081 0.042 CID_154700008 | CID_154700008 | |
| 0.006 | 0.135 | 0.023 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.023 0.012 CID_154700008 | CID_154700008 | |
| 0.085 | 0.215 | 0.339 | DNA methyltransferase I inhibitor | 0.339 0.016 CID_154700008 | CID_154700008 | |
| 0.016 | 0.157 | 0.082 | Adenosine A1 receptor antagonist | 0.082 0.028 CID_154700008 | CID_154700008 | |
| 0.083 | 0.227 | 0.148 | Nitric oxide antagonist | 0.148 0.096 CID_154700008 | CID_154700008 | |
| 0.022 | 0.166 | 0.069 | Antineoplastic antibiotic | 0.069 0.066 CID_154700008 | CID_154700008 | |
| 0.054 | 0.201 | 0.16 | AMP-activated protein kinase stimulant | 0.16 0.022 CID_154700008 | CID_154700008 | |
| 0.009 | 0.158 | 0.031 | Phosphoglycerate kinase inhibitor | 0.031 0.03 CID_154700008 | CID_154700008 | |
| 0.099 | 0.249 | 0.239 | Vasodilator | 0.239 0.076 CID_154700008 | CID_154700008 | |
| 0.006 | 0.157 | 0.032 | Purinergic P2X agonist | 0.032 0.016 CID_154700008 | CID_154700008 | |
| 0.011 | 0.165 | 0.052 | Purinergic P2Y antagonist | 0.052 0.025 CID_154700008 | CID_154700008 | |
| 0.052 | 0.206 | 0.091 | Transcription factor NF kappa B stimulant | 0.091 0.049 CID_154700008 | CID_154700008 | |
| 0.077 | 0.258 | 0.349 | DNA methylase inhibitor | 0.349 0.017 CID_154700008 | CID_154700008 | |
| 0.017 | 0.204 | 0.065 | Protein 50S ribosomal subunit inhibitor | 0.065 0.027 CID_154700008 | CID_154700008 | |
| 0.056 | 0.254 | 0.37 | Angiogenesis stimulant | 0.37 0.028 CID_154700008 | CID_154700008 | |
| 0.05 | 0.25 | 0.154 | Cytidine deaminase inhibitor | 0.154 0.072 CID_154700008 | CID_154700008 | |
| 0.072 | 0.273 | 0.224 | Hepatoprotectant | 0.224 0.053 CID_154700008 | CID_154700008 | |
| 0.098 | 0.302 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.101 CID_154700008 | CID_154700008 | |
| 0.017 | 0.223 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.025 CID_154700008 | CID_154700008 | |
| 0.038 | 0.257 | 0.101 | Uric acid excretion stimulant | 0.101 0.051 CID_154700008 | CID_154700008 | |
| 0.113 | 0.369 | 0.332 | Antibacterial | 0.332 0.113 CID_154700008 | CID_154700008 | |
| 0.127 | 0.408 | 0.333 | Cyclophilin D inhibitor | 0.333 0.135 CID_154700008 | CID_154700008 | |
| 0.012 | 0.315 | 0.073 | Selectin antagonist | 0.073 0.041 CID_154700008 | CID_154700008 | |
| 0.005 | 0.312 | 0.021 | Adenosine A3 receptor agonist | 0.021 0.008 CID_154700008 | CID_154700008 | |
| 0.024 | 0.39 | 0.181 | Cell adhesion molecule inhibitor | 0.181 0.011 CID_154700008 | CID_154700008 | |
| 0.048 | 0.422 | 0.135 | Insulin secretagoues | 0.135 0.091 CID_154700008 | CID_154700008 | |
| 0.023 | 0.408 | 0.136 | Aminoacyl-tRNA synthetase inhibitor | 0.136 0.023 CID_154700008 | CID_154700008 | |
| 0.033 | 0.44 | 0.234 | Cell adhesion inhibitor | 0.234 0.017 CID_154700008 | CID_154700008 | |
| 0.079 | 0.507 | 0.204 | Apoptosis antagonist | 0.204 0.174 CID_154700008 | CID_154700008 | |
| 0.005 | 0.435 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.008 CID_154700008 | CID_154700008 | |
| 0.097 | 0.538 | 0.337 | Antiinflammatory | 0.337 0.183 CID_154700008 | CID_154700008 | |
| 0.005 | 0.446 | 0.018 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.018 0.008 CID_154700008 | CID_154700008 | |
| 0.02 | 0.576 | 0.162 | Platelet antagonist | 0.162 0.133 CID_154700008 | CID_154700008 | |
| 0.041 | 0.612 | 0.205 | Hypoglycemic | 0.205 0.107 CID_154700008 | CID_154700008 | |
| 0.003 | 0.582 | 0.038 | Adenosine A1 receptor agonist | 0.038 0.008 CID_154700008 | CID_154700008 | |
| 0.02 | 0.713 | 0.196 | Platelet adhesion inhibitor | 0.196 0.073 CID_154700008 | CID_154700008 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |